BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22340235)

  • 21. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
    Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
    Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
    Xiang X; Zhao WB; Wang X
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):661-4. PubMed ID: 19785952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
    Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
    Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma].
    Hou YK; Wang Y; Cong WM; Wu MC
    Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of CXCR3 in hepatocellular carcinoma].
    Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
    Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
    Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
    Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.
    Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
    Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
    Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of vascular endothelial growth factor correlates with invasion and metastasis of hepatocellular carcinoma].
    Li X; Tang Z; Zhou G
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):12-4. PubMed ID: 10921046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of HIWI in human hepatocellular carcinoma.
    Jiang J; Zhang H; Tang Q; Hao B; Shi R
    Cell Biochem Biophys; 2011 Sep; 61(1):53-8. PubMed ID: 21327579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
    Chen L; Shen AG; Wang GL; Lu P; Li XY
    Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
    Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
    Li XM; Tang ZY; Qin LX; Zhou J; Sun HC
    J Exp Clin Cancer Res; 1999 Dec; 18(4):511-7. PubMed ID: 10746978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and clinical significance of HIF-1a protein in hepatocellular carcinoma tissues].
    Ding L; Chen XP; Wang HP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):656-9. PubMed ID: 15623372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.